YKL-40 expression and its polymorphism in human breast carcinoma : A potential biomarker

Chitinase-3-like protein1 (YKL-40) as biomarker in serum of breast cancer females

Osteoprotegerin as a prognostic marker in patients with breast cancer

RANKL as a prognostic marker in patients with breast cancer

RANKL and osteoprotegerin gene polymorphisms and their protein levels in breast cancer patients

Comparison of serum YKL-40 biomarker levels in primary prostate cancer and recurrent cases after radiotherapy

Relationship between the expression of apoptosisrelatedbiomarkers and the pathologic response toneoadjuvant chemotherapy in primary breastcarcinomas

Biochemical markers of bone metabolism in breast cancer patients with bone metastases

Study of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) MRNA expression in patients with systemic lupus erythematosus

Estimation of serum bcl-2 as a marker of apoptosis in type II diabetes